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Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33S4sugar, insulin, HbA1C, lipid proﬁle were done . We used IDF (Interna-
tional diabetes federation) criteria to assess the metabolic syndrome
among cancer survivors. This study was approved by our university
ethics comittee.
Results: Seventy ﬁve children who fulﬁlled the inclusion criteria were
included in this study, out of which 48 were males and 27 were females.
Among these, majority of children are treated for acute lymphoblastic
leukemia. 8.25% of total population satisﬁed the criteria of metabolic
syndrome. Age, gender, diagnosis, modality of treatment were not to be of
statistical signiﬁcance, however majority of children with metabolic syn-
drome are in adolescent group.
Conclusion: With the better care committed to childrenwith cancer even in
developing country, the survival rates are greatly improving and so meta-
bolic syndrome is becoming the major target for intervention in the follow
up of cancer survivors. As metabolic syndrome cannot treated by a single
drug therapy, it is necessary to have cancer survivors follow up screening.
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FORGOTTEN MEMBER OF THE FAMILY?; SIBLINGS OF CHILDREN WITH
CANCER e THE PSYCHOSOCIAL IMPACT OF THE DIAGNOSIS IN THE
SIBLINGS!
Rachel Priyanka Pulla, Jigisa Tripathy, M.S. Latha, Lalitha
Subramanian, Julius Xavier Scott. Sri Ramachandra Medical College and
Research Institute, Chennai, Porur 600116, India
Introduction: Siblings of the family are exposed to signiﬁcant stress when
a child is diagnosed with cancer. Concern about the ill child, disruptions in
family roles/ routines, decreased contact with family members, and addi-
tional demands for caregiving/other responsibilities in the home are
common after a cancer diagnosis in the family household. In some cases,
siblings are also called upon to serve as a donor for stem cell transplant,
which can introduce other ethical and psychosocial concerns. These unique
challenges leave siblings of children with cancer at risk for acute and long-
term psychosocial difﬁculties. However, there are no current evidence-
based standards for the supportive care of siblings of childrenwith cancer.
Methodology: The Objectives of the study was to assess the psychosocial
impact of childhood cancer on siblings.
The study was conducted in two survivor camps at Sri Ramachandra
Medical College and Research Institute, a tertiary centre for paediatric
haemato-oncology. An interviewer administered questionnaire was
applied, which was framed after thorough literature review along with
clinical psychologists contributions and validated by national and inter-
national paediatric oncologists. Parents and siblings were interviewed
after obtaining appropriate consent. The questionnaire focuses on 5
essential domains: Medical, Well-Being, Emotional, Scholastic, and Social
performance (family time). Other domains like social withdrawal, food
habits and behavioural changes were analysed.
Results: 44 siblings of cancer children were included in this study. Sig-
niﬁcant experiences of negative emotional reactions (lonely, depressed,
sadness, unwanted, anger, and guilt) were expressed. Out of which, the
majority of 48% were depressed and 26% were found to be angry. Academic
performance of 58% were affected. The poor quality of life in the categories
of emotional, family, and social domains showed a signiﬁcant rise of per-
centage, coming up to 96.7% of compromised leisure activities.
Family-level themes such as loss of attention was signiﬁcant in 77% of the
group that was studied. Positive outcomes including increased sibling
maturity, empathy and learning to take responsibilities was observed by
the family in 88.9% of the study group. 18% were oriented towards showing
interest in participating for social cause in the future.
Conclusions:
 Research regarding siblings of children with cancer continues to be
methodologically limited particularly in a developing country such asIndia.
 Siblings of children with cancer are psychosocially at-risk group and
should be provided with appropriate supportive services.
 Early identiﬁcation of behavioral changes is mandatory.
 Appropriate interventions should be developed.
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Nishant Verma, Archana Kumar, Vishal Pooniya. King George's Medical
University, Lucknow, UP, India
E-mail address: drnishantaiims@gmail.com (N. Verma).
Background/Objective: Outcome of childhood cancer in Low Middle in-
come countries (LMIC) like India continues to be poor as compared to
High-income countries. One of the proposed reasons for this poor outcome
is delay in diagnosis and treatment. There are only few studies from LMICs
which look into the magnitude of delays and reasons behind them.
Methods: A prospective observational study was conducted in the Pedi-
atric Oncology Unit at KGMU, Lucknow, UP from 01/01/2015 to 30/06/2015.
All the newly diagnosed childhood cancer patients were included in this
study. Parents of these children were interviewed and data regarding the
date of onset of symptoms, date of ﬁrst contact with a health care pro-
fessional, date of ﬁrst visit to a pediatric oncology center, date of diagnosis
and date of treatment initiation were recorded onto a standard proforma.
Figure 1 describes the deﬁnition of various types of delays used for this
study. Demographic and clinical details were recorded from hospital
medical records.
Results: Parents of 111 children with newly diagnosed childhood cancer
were interviewed. Median total delay for the entire cohort was 58 days
(IQR 33-97). The most important contributor to this total delay was delay
in referral (median-40d; IQR 17-80d). Patient delay (median-5d), Diag-
nostic delay (median-4d) and Treatment delay (median-2d), were signif-
icantly lower than Referral delay. While girls had a higher total delay
(median-67d) as compared to boys (median-50d) (P¼0.046), place of
residence of family (Rural vs Urban), family income (below poverty line vs
above poverty line) and education status of the parents did not affect the
delay. Total delay was least in children with Wilms tumor (median-27d)
and acute leukemia (median-42d) and maximum in Hodgkins lymphoma
(median-285d). All the children had consulted at least one medical pro-
fessional (median-3, range 1-20) before coming to oncology center. 21% of
parents gave a history of using alternative form of medicine. Using alter-
native treatment was associated with longer total delay (median 69d vs
49d; P¼0.012). Parents of 10 children (9%) believed that cancer is incurable
and this belief was instigated in them either by relatives (7) or doctors (3).
Common causes of delay, which were identiﬁed were inadequate referral
(in 76% children) and ﬁnancial constraints for the family (in 35% children).
After the ﬁnal diagnosis of cancer was established, 14% children (15/111)
abandoned before any treatment could be established. 14 of these families
could be tracked using phone calls. The reasons, which they cited for
abandonment included ﬁnancial burden of treatment (9/14), too many
investigations (9/14) and belief that cancer is incurable (6/14).
Conclusions: Referral delay was recognized as the biggest hindrance for
timely management of childhood cancer in our region. There is a need to
train health care providers at primary, secondary and tertiary levels to help
early recognition of cancer symptoms and prompt referral to appropriate
pediatric oncology centers. Steps should also be taken to prevent inap-
propriate use of alternative forms of treatment for childhood cancer as it
interferes with timely diagnosis and referral.
Figure 1. Diagrammatic representation of various types of delays in the management
of childhood cancer.
